Tag: Camurus

As Sweden’s most valuable biotech company, Camurus stands out with its unique platform for the sustained release of therapies. With multiple products on the market, Camurus is a key player in both the biotech and pharmaceutical industries.

Camurus CEO Fredrik Tiberg on Long-Acting Opioid Treatment

Camurus CEO Fredrik Tiberg on Long-Acting Opioid Treatment

Turning Generics Into Game-Changing Therapies: Fredrik Tiberg of Camurus Explains the Power of Long-Acting Medicines...

Camurus drug development

• Feb 24, 2026

Fredrik Tiberg, Camurus 🇸🇪 | Opioid Crisis, Long-Acting Injections | E51

Fredrik Tiberg, Camurus 🇸🇪 | Opioid Crisis, Long-Acting Injections | E51

Founded in 1991, Camurus has grown into a $4B biotech with two products in the...

Camurus drug development

• Feb 2, 2026

The 25 Most Valuable Biotech Companies in Europe in 2025

The 25 Most Valuable Biotech Companies in Europe in 2025

The biotech industry in Europe is booming, with companies making groundbreaking medical advances, from oncology...

argenx Ascendis Pharma

• May 19, 2025

Watch & Subscribe

Flot.bio on Youtube

Flot.bio on Spotify

Flot.bio on Apple Podcasts